![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euroapi-corp-ad-w30-desktop-header-1-2gif-57087.gif)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euro-api-mob-header-w30gif-19381.gif)
X
20
Maithri Drugs Private Limited Bonthapally Village In, based in India, is a pharmaceutical company.
One of their significant offerings is Mirtazapine, Route code "ZA", supported by a 'Valid' Certificate of Suitability (CEP) with the number CEP 2018-225 - Rev 01
This Chemical Type CEP, issued on April 10, 2024, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 2338 associated with this CEP further emphasizes